$TISI Cashflow Statement | Understand Stock

$TISI

$23.82 +$0.01 (0.04%) Close

$TISI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization
Write-off of deferred loan costs
Gain on sale of Quest Integrity
Loss on debt extinguishment
Loss on warrants
Write-off of software cost
Amortization of debt issuance costs, debt discounts, and deferred financing costs
Paid-in-kind (PIK) interest
Allowance for credit losses
Foreign currency loss (gain)
Deferred income taxes
Loss (gain) on asset disposal
Non-cash compensation costs
Other, net
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other assets
Accounts payable
Other accrued liabilities
Income taxes

Net cash provided by (used in) operating activities
Cash flows from investing activities:
Capital expenditures
Business acquisitions, net of cash acquired
Net proceeds from sale of discontinued operations
Proceeds from disposal of assets
Other
Net cash used in investing activities

Cash flows from financing activities:
Net payments under Credit Facility revolver
Borrowings under ABL Facility, net
Borrowings under 2020 ABL Facility, gross
Payments under 2020 ABL Facility, gross
Borrowings under Revolving Credit Loans
Revolving Credit loans
Total borrowings under Revolving Credit Loans

Borrowings under Incremental Term Loan
Borrowings under First Lien Term Loan
Delayed Draw Term Loan
First Lien Term Loan
ME/RE Loans
Total borrowings under First Lien Term Loan

Borrowings under Subordinated Term Loan, gross
Borrowings (payments) under Credit Facility term loan, net of debt discount
Borrowings under 2020 ABL Credit Facility, net
Payments under First Lien Term Loan, 2025 Second Lien Term Loan, Corre Delayed Draw Term Loan and ME/RE Loans
First Lien Term Loan
2025 Second Lien Term Loan
Delayed Draw Term Loan
ME/RE Loans
Repayment of APSC Term Loan
Atlantic Park Term Loan
Total repayment of APSC Term Loan

Payments under Corre Incremental Term Loan
Repayment of Convertible Debt
Contingent consideration payments
Payments under Corre Uptiered Loan
Proceeds from issuance of Series B Preferred Stock and warrants
Issuance cost related to Series B Preferred Stock and warrants
Payments for debt issuance costs
Issuance of common stock, net of issuance costs
Taxes paid related to net share settlement of share-based awards
Payments for debt extinguishment and equity reacquisition costs
Other
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental Cash Flow Information
Cash paid during the year for:
Interest
Income taxes
Non-cash investing and financing activities:
Assets acquired under finance lease
Equipment financed with notes payable
Accrued capital expenditures

Comments